These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20539075)

  • 1. The relationship between economic evaluations and HIV and AIDS treatment policies.
    Taleski SJ; Ahmed K; Whiteside A
    Curr Opin HIV AIDS; 2010 May; 5(3):204-9. PubMed ID: 20539075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic impact of HIV.
    Veenstra N; Whiteside A
    Best Pract Res Clin Obstet Gynaecol; 2005 Apr; 19(2):197-210. PubMed ID: 15778110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of socioeconomic impact assessments of HIV/AIDS.
    Forsythe S; Rau B
    AIDS; 1998; 12 Suppl 2():S47-55. PubMed ID: 9792361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The affordability of antiretroviral therapy in developing countries: what policymakers need to know.
    Forsythe SS
    AIDS; 1998; 12 Suppl 2():S11-8. PubMed ID: 9792357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macroeconomic impact of HIV: the need for better modelling.
    Lamontagne E; Haacker M; Ventelou B; Greener R
    Curr Opin HIV AIDS; 2010 May; 5(3):249-54. PubMed ID: 20539082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of HIV/AIDS workplace policies and programmes in southern Africa.
    Mahajan AP; Colvin M; Rudatsikira JB; Ettl D
    AIDS; 2007 Jul; 21 Suppl 3():S31-9. PubMed ID: 17666960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economics of effective AIDS treatment in Thailand.
    Over M; Revenga A; Masaki E; Peerapatanapokin W; Gold J; Tangcharoensathien V; Thanprasertsuk S
    AIDS; 2007 Jul; 21 Suppl 4():S105-16. PubMed ID: 17620745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic impact of delaying or preventing AIDS in persons with HIV.
    Pinkerton SD; Holtgrave DR
    Am J Manag Care; 1999 Mar; 5(3):289-98. PubMed ID: 10351025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limits to evidence-based health policymaking: policy hurdles to structural HIV prevention in Tanzania.
    Hunsmann M
    Soc Sci Med; 2012 May; 74(10):1477-85. PubMed ID: 22445763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic modeling of HIV treatments.
    Simpson KN
    Curr Opin HIV AIDS; 2010 May; 5(3):242-8. PubMed ID: 20539081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic research on HIV prevention, care and treatment: why it is more than ever needed?
    Moatti JP; Eboko F
    Curr Opin HIV AIDS; 2010 May; 5(3):201-3. PubMed ID: 20539074
    [No Abstract]   [Full Text] [Related]  

  • 12. The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001.
    Krentz HB; Auld MC; Gill MJ;
    CMAJ; 2003 Jul; 169(2):106-10. PubMed ID: 12874156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs associated with combination antiretroviral therapy in HIV-infected patients.
    Yazdanpanah Y
    J Antimicrob Chemother; 2004 Apr; 53(4):558-61. PubMed ID: 14985277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic reviews of economic evaluations: utility or futility?
    Anderson R
    Health Econ; 2010 Mar; 19(3):350-64. PubMed ID: 19378354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Time is costly': modelling the macroeconomic impact of scaling-up antiretroviral treatment in sub-Saharan Africa.
    Ventelou B; Moatti JP; Videau Y; Kazatchkine M
    AIDS; 2008 Jan; 22(1):107-13. PubMed ID: 18090398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining prevention, treatment and care: lessons from South Africa.
    Achmat Z; Simcock J
    AIDS; 2007 Jul; 21 Suppl 4():S11-20. PubMed ID: 17620746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The National Strategic Plan of South Africa: what are the prospects of success after the repeated failure of previous AIDS policy?
    Wouters E; van Rensburg HC; Meulemans H
    Health Policy Plan; 2010 May; 25(3):171-85. PubMed ID: 19955092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.